Atlas Trials

Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.

Clinical trial NCT00282620 · UNKNOWN

Trial details

NCT number
NCT00282620
Sponsor
Hartford Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
ArrhythmiaQuality of LifeHypomagnesemia
Start date
2006-01-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.